Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

Authors

Hildrun Haibel

Published

June 24, 2008

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

Arthritis & Rheumatism

Topics

DOI

10.1002/art.23606

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

Authors

Hildrun Haibel

Published

June 24, 2008

Add a comment...

Supporters

Support the authors with ResearchCoin

Journal

Arthritis & Rheumatism

Topics

DOI

10.1002/art.23606

Paper

Paper

Paper

Paper

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

Supporters

Journal

Topics

DOI

Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: Results of a twelve‐week randomized, double‐blind, placebo‐controlled trial followed by an open‐label extension up to week fifty‐two

Supporters

Journal

Topics

DOI